Study finds minimally invasive procedure could spread uterine cancer

A new study released Tuesday in The Journal of the American Medical Association cautions doctors about using power morcellation to remove the uterus, a procedure close to 50,000 women undergo each year.
Considered to be minimally invasive, power morcellation uses a device to cut uterine tissue into smaller pieces that are then removed via tiny incisions. However, researchers discovered that it's more common than previously thought for a woman undergoing the procedure to have undetected cancer; if the device cuts tumors they might spread cancer cells through the abdomen.
Researchers looked at a database that included 15 percent of hospitalizations in the U.S. from 2006 to 2012. They found 232,882 cases of minimally invasive hysterectomies, including 36,470 women who had power morcellation. Of those patients, 99 were subsequently found to have uterine cancer, meaning one in 368 women who had hysterectomies had cancerous tumors, Dr. Jason D. Wright, the lead author and chief of gynecologic oncology at Columbia University College of Physicians and Surgeons, told The New York Times. Had doctors known about the cancer, they would not have performed the power morcellation.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Researchers also reviewed the cases of a doctor at Dana-Farber Cancer Institute, and found that cancer spread much faster after morcellation was used to remove a uterus than major abdominal surgery. Wright isn't calling for a stop to the procedure, but is advocating for education. "I don't know that necessarily morcellation should be banned," he said. "But this data is important to allow people to make decisions."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published